Trials / Completed
CompletedNCT03800290
Human Beta-2 Adrenergic Stimulation and Muscle Glucose Uptake
Targeting the Beta-2-adrenergic Pathway to Improve Skeletal Muscle Glucose Uptake in Healthy Humans
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 11 (actual)
- Sponsor
- Maastricht University · Academic / Other
- Sex
- Male
- Age
- 18 Years – 30 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to investigate the effect of two weeks clenbuterol/placebo supplementation on skeletal muscle glucose disposal in healthy male volunteers.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Clenbuterol Hydrochloride | Daily ingestion of clenbuterol hydrochloride capsules (40 microgram/day) for a total period of 14 days with a wash-out period of 4 weeks. |
| DRUG | Placebos | Daily ingestion of placebo capsules for a total period of 14 days with a wash-out period of 4 weeks. |
Timeline
- Start date
- 2019-06-01
- Primary completion
- 2021-04-23
- Completion
- 2021-04-23
- First posted
- 2019-01-11
- Last updated
- 2022-12-01
Locations
1 site across 1 country: Netherlands
Source: ClinicalTrials.gov record NCT03800290. Inclusion in this directory is not an endorsement.